Trinity Biotech receives non-compliance notice from Nasdaq

Trinity Biotech (TRIB) received notice from the Nasdaq Stock Market LLC that the company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of $1.00 per share, based on the closing bid price of the company’s American depositary shares for the last 30 consecutive business days. The company also received notice today that the company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares of $15,000,000, based on Nasdaq’s review of the company’s MVPHS for the last 30 consecutive business days. These notices have no immediate effect on the listing of the company’s ADSs, which will continue to trade at this time on the Nasdaq Global Select Market under the symbol “TRIB.”